Skip to main content
Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,260
+250 (1.78%)
Apr 29, 2026, 3:30 PM KST

KRX:271980 Revenue

In the year 2025, Jeil Pharmaceutical Co.,Ltd had annual revenue of 567.24B KRW, down -19.49%. Jeil Pharmaceutical Co.,Ltd had revenue of 131.83B in the quarter ending December 31, 2025, a decrease of -29.34%.

Revenue
567.24B
Revenue Growth
-19.49%
P/S Ratio
0.37
Revenue / Employee
598.99M
Employees
947
Market Cap
207.79B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025567.24B-137.30B-19.49%
Dec 31, 2024704.54B-21.85B-3.01%
Dec 31, 2023726.39B4.16B0.58%
Dec 31, 2022722.23B21.54B3.07%
Dec 31, 2021700.69B9.37B1.36%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samil Pharmaceutical Co.,Ltd 210.25B
REYON Pharmaceutical 145.93B
JW Lifescience 257.83B
SAMSUNG PHARM. Co., LTD. 44.29B
Whan In Pharm 255.21B
Ilyang Pharmaceutical Co.,Ltd 272.42B
AptaBio Therapeutics 3.70B
Suheung 722.31B
Revenue Rankings